BlinkLab Limited

BlinkLab Limited: Transforming Mental Healthcare through Mobile-based AI App


Australia-based BlinkLab leverages computer vision, artificial intelligence and machine learning by developing an app-enabled, smartphone-based diagnostic tool for evaluating children with neurodevelopmental conditions such as autism and ADHD. The app turns the mobile phone into a medical device for an effortless way of conducting remote and rapid tests.

The BlinkLab Test aims to perform neurobehavioural testing free from facial instruments or other fixed location equipment. This AI-based platform is designed to be used at home or in similar environments, independently or with the assistance of a caregiver while following instructions from the mobile device application.

Blinklab test

In collaboration with Princeton University in the US and Erasmus Medical Center in the Netherlands, Blinklab Test is initially developed as a prescription diagnostic aid to healthcare professionals (HCP). BlinkLab will need to complete a pivotal registrational study and subsequently apply for FDA registration and reimbursement for the tests.

Company Highlights

  • Australia-based BlinkLab is focused on transforming mental healthcare through an AI-enabled smartphone application, a breakthrough technology developed at Princeton University.
  • The company’s innovative approach leverages the power of smartphones, AI and machine learning to deliver screening tests specifically designed for children as young as 18 months old. This marks a significant advancement, considering traditional diagnoses typically occur around five years of age, often missing the crucial early window for effective intervention.
  • Once approved by the regulators, this cutting-edge digital technology is poised to capture the imagination of both investors and major pharmaceutical companies, eager to embrace transformative solutions in healthcare.
  • BlinkLab is led by an experienced management team and leading experts in the field of machine learning, autism and brain development bridging the most advanced technological innovations with groundbreaking scientific research. The company is chaired by Brian Leedman, an experienced biotechnology entrepreneur and founder of ResApp Health, a digital diagnostic company recently acquired by Pfizer.

This BlinkLab is part of a paid investor education campaign.*

Click here to connect with BlinkLab to receive an Investor Presentation

The Conversation (0)
Computer and phone screens showing Microsoft Azure information.

Microsoft Unveils Expanded AI Solutions to Support Healthcare Sector

Microsoft (NASDAQ:MSFT) announced a range of new innovations under its Microsoft Cloud for Healthcare platform on October 10, saying it is looking to reshape healthcare delivery via artificial intelligence (AI).

Among the offerings is the introduction of healthcare-specific AI models in Azure AI Studio. These models have been built to manage complex healthcare data types, include medical imaging, genomic and clinical records data.

According to the company, by using these models, healthcare organizations will gain the ability to develop tailored AI applications and systems that address their unique operational needs.

Keep reading...Show less
Close up of phone showing AlphaFold logo.

Tech 5: AI Advances Win Nobel Prizes, Autonomous Tesla Falls Flat

The Royal Swedish Academy of Sciences recognized advancements in artificial intelligence (AI) this week, handing out two prizes to researchers working in the field.

Meanwhile, Bitcoin's price movements showed that the cryptocurrency is still heavily influenced by macroeconomic factors, and Tesla (NASDAQ:TSLA) finally gave investors a glimpse of its long-awaited full autonomous vehicle, leaving them unimpressed.

At OpenAI, financial projections reveal that profits are still a ways away.

Keep reading...Show less
AI brain on computer screen with several medical devices.

Suki Secures US$70 Million to Drive AI-Assisted Healthcare Solutions

Suki AI, a healthcare-focused startup, has secured US$70 million in a Series D funding round aimed at further developing its artificial intelligence (AI) assistant tools for hospitals and medical providers.

Reuters reported on October 10 that the latest round brings the company’s total funding to US$165 million and, according to sources familiar with the deal, values Suki at around US$500 million.

Founded in 2017 by Punit Soni, a former Google (NASDAQ:GOOGL) and Flipkart executive, Suki specializes in developing AI-powered voice assistants designed to alleviate the administrative burden placed on healthcare professionals.

Keep reading...Show less
A computer chip with AI written on it.

TSMC Shatters Q3 Estimates with 36.5 Percent Revenue Increase

Taiwan Semiconductor (TSMC) (NYSE:TSM,TPE:2330), the world’s largest contract chipmaker, reported a strong 39.6 percent year-over-year increase in revenue for September 2024.

Based on this, the company's Q3 earnings beat analysts' expectations and the company's own guidance, rising 36.5 percent year-over-year. For the quarter ending September 30, TSMC posted revenues of NT$759.7 billion (US$23.5 billion), surpassing the projected NT$748 billion. The company will disclose its full Q3 earnings report on October 19.

Bloomberg reported that the company’s performance has eased concerns over a potential slowdown in demand for artificial intelligence (AI) hardware, which has been a significant driver of the global semiconductor market in recent years.

Keep reading...Show less
BlinkLab Limited

BlinkLab’s ASD, ADHD Diagnostic App Gets ‘Speculative Buy’ Rating from Lodge Partners

Description:

Privately owned research and corporate finance firm Lodge Partners recommends a ‘speculative buy’ for BlinkLab’s (ASX:BB1) autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD) diagnostic app.

Keep reading...Show less
Hand holding an AI chip.

AI Stocks: 9 Biggest Companies in 2024

Artificial intelligence (AI) may be an emerging technology, but there are plenty of billion-dollar companies in this space.

As the market has grown over the past few years, AI technology has made strong inroads into several key industries, including logistics, manufacturing, finance, healthcare, customer service and cybersecurity.

While AI-driven advancements in robotics have received the most press in recent years, the largest buzz has centered around OpenAI’s ChatGPT. This intelligent chatbot shows how quickly generative AI is advancing, and has attracted the attention of heavyweight technology companies such as Microsoft (NASDAQ:MSFT), which has reportedly invested billions of dollars in the privately held OpenAI. Alphabet (NASDAQ:GOOGL) has also released its own AI chat tool, Google Gemini.

On a global scale, Fortune Business Insights predicts that the AI industry will experience a compound annual growth rate of 20.4 percent between 2024 and 2032 to reach a market value of more than US$2.74 trillion.

Keep reading...Show less

Latest Press Releases

Related News

×